Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHRN | KBH |
|---|---|---|
| Price | $18.72 | $45.36 |
| Change today | ▲ 0.62% | ▲ 0.71% |
| Market cap | $2.73B | $2.76B |
| Return, 3 months | +6.8% | -22.4% |
| Return, year to date | +116.6% | -18.5% |
| Return, 1 year | +240.9% | -28.4% |
| P/E (TTM) | -52.0 | 12.8 |
| P/B | 15.1 | 0.7 |
| P/E percentile vs own 5y | 3rd | 95th |
| Dividend yield | – | 2.20% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +71.0% | +21.1% |
| Analyst buy share | 100% | 23% |
| RSI (14) | 43 | 29 |
| 30-day volatility | 84.3% | 28.8% |
| Max drawdown, 1 year | -40.4% | -31.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
